2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
37
CNC Quote, Financials, Valuation and Earnings
Last price:
$56.43
Seasonality move
:
0.15%
Day range:
$56.08 - $57.27
52-week range:
$55.03 - $80.59
Dividend yield:
0%
P/E ratio:
8.41x
P/S ratio:
0.17x
P/B ratio:
1.01x
Volume:
6.7M
Avg. volume:
5.3M
1-year change:
-18.16%
Market cap:
$28.1B
Revenue:
$163.1B
EPS (TTM):
$6.71
Analysts' Opinion
-
Consensus RatingCentene has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $78.09, Centene has an estimated upside of 38.37% from its current price of $56.44.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $61.00 representing 100% downside risk from its current price of $56.44.
Fair Value
-
According to the consensus of 16 analysts, Centene has 38.37% upside to fair value with a price target of $78.09 per share.
CNC vs. S&P 500
-
Over the past 5 trading days, Centene has underperformed the S&P 500 by -4.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Centene does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Centene has grown year-over-year revenues for 69 quarters straight. In the most recent quarter Centene reported revenues of $46.6B.
Earnings Growth
-
Centene has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Centene reported earnings per share of $2.63.
Enterprise value:
29.2B
EV / Invested capital:
0.63x
Price / LTM sales:
0.17x
EV / EBIT:
5.59x
EV / Revenue:
0.17x
PEG ratio (5yr expected):
0.25x
EV / Free cash flow:
19.58x
Price / Operating cash flow:
19.43x
Enterprise value / EBITDA:
4.51x
Gross Profit (TTM):
$17.4B
Return On Assets:
4.13%
Net Income Margin (TTM):
2.04%
Return On Equity:
12.65%
Return On Invested Capital:
7.62%
Operating Margin:
3.29%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $146.3B | $155.5B | $169.3B | $40.4B | $46.6B | |
| Gross Profit | $16.9B | $17.4B | $17.4B | $4.6B | $5.2B | |
| Operating Income | $3.6B | $3.3B | $3.6B | $1.1B | $1.5B | |
| EBITDA | $4.3B | $5.7B | $6.5B | $2B | $2.2B | |
| Diluted EPS | $2.64 | $5.03 | $6.71 | $2.16 | $2.63 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $24.4B | $31.1B | $35B | $38.4B | $41.3B | |
| Total Assets | $70.3B | $82.9B | $83B | $82.6B | $87B | |
| Current Liabilities | $22.3B | $29.7B | $32.9B | $32.8B | $37.1B | |
| Total Liabilities | $43.7B | $55.5B | $57.8B | $55.6B | $59B | |
| Total Equity | $26.5B | $27.4B | $25.2B | $27.1B | $28B | |
| Total Debt | $16.8B | $18.9B | $18.3B | $18B | $18.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $9.4B | $3.3B | $2.1B | -$456M | $1.5B | |
| Cash From Investing | -$773M | -$86M | -$2.4B | $852M | -$529M | |
| Cash From Financing | -$3.9B | -$1.5B | -$2.7B | $23M | -$250M | |
| Free Cash Flow | $8.4B | $2.6B | $1.5B | -$607M | $1.4B | |
CNC
Sector
Market Cap
$28.1B
$34.1M
Price % of 52-Week High
70.03%
45.43%
Dividend Yield
0%
0%
Shareholder Yield
9.52%
-0.66%
1-Year Price Total Return
-18.16%
-39.29%
Beta (5-Year)
0.478
0.653
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$57.97
200-day SMA
Sell
Level
$63.93
Bollinger Bands (100)
Sell
Level
58.09 - 62.89
Chaikin Money Flow
Buy
Level
9.9M
20-day SMA
Sell
Level
$59.81
Relative Strength Index (RSI14)
Sell
Level
39.77
ADX Line
Sell
Level
18.46
Williams %R
Buy
Level
-91.5677
50-day SMA
Sell
Level
$60.40
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Sell
Level
-25.4M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8137)
Buy
CA Score
(Annual)
Level (-0.29)
Sell
Beneish M-Score
(Annual)
Level (-2.0011)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.4217)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Stock Forecast FAQ
In the current month, CNC has received 7 Buy ratings 9 Hold ratings, and 0 Sell ratings. The CNC average analyst price target in the past 3 months is $78.09.
-
Where Will Centene Stock Be In 1 Year?
According to analysts, the consensus estimate is that Centene share price will rise to $78.09 per share over the next 12 months.
-
What Do Analysts Say About Centene?
Analysts are divided on their view about Centene share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Centene is a Sell and believe this share price will drop from its current level to $61.00.
-
What Is Centene's Price Target?
The price target for Centene over the next 1-year time period is forecast to be $78.09 according to 16 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is CNC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Centene is a Hold. 9 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CNC?
You can purchase shares of Centene via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Centene shares.
-
What Is The Centene Share Price Today?
Centene was last trading at $56.43 per share. This represents the most recent stock quote for Centene. Yesterday, Centene closed at $56.44 per share.
-
How To Buy Centene Stock Online?
In order to purchase Centene stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
